Hepatitis A Vaccine (Human Diploid Cell), Inactivated – Healive^®

Launched in 2002

Hepatitis A & Hepatitis B Combined Vaccine – Bilive^®

Launched in 2005

Healive^® is:

• Prequalified by the World Health Organization.

• Provides sustained protection for over 30 years after full immunization, according to model predictions.

• Has a good safety profile and can be used in people with special health conditions.

• Exported to more than 30 countries and used in many national immunization programs, after two decades in the marketplace.

In 2005, SINOVAC launched a combination vaccine against hepatitis A and B based on Healive^®. It provides simultaneous protection against both diseases.